Bigger is Not Better! Significant Milestone for Stereotaxis and GenesisX! Stereotaxis just achieved a significant milestone, securing CE mark approval in Europe and submitting an FDA 510(k) application for their new GenesisX surgical robot. This cutting-edge system is a prime example of how medtech companies are moving towards surgical robotics platforms that are more accessible, smaller, and easier to implement and deploy, simplifying hospital integration and advancing patient care. GenesisX is a refined iteration of Stereotaxis' Genesis robotic magnetic navigation (RMN) system. It breaks down previous barriers by designing a more compact and efficient setup. Gone are the days of complex structural modifications and hefty installations. GenesisX uses smaller magnets and needs only standard power outlets, making it accessible for more hospitals. With these improvements, GenesisX promises swift, responsive performance and seamless workflow. As Stereotaxis aims for a full launch in 2025, the company plans to gather real-world data, secure additional regulatory approvals, and prepare the supply chain. This innovation opens doors for broader adoption in electrophysiology and endovascular procedures, bringing advanced robotic solutions to more patients. #MedTech #SurgicalRobotics #HealthcareInnovation
Significant milestone!
MedTech Executive Recruiter | Building world-class teams, one strategic hire at a time.
4moAnother great example architecture designed around adoptability.